SNT 20 Jul 2026, 10:01 AM

AZALOX MDS study advances to final Phase 1b cohort

Syntara Ltd

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in